WallStSmart

Modiv Inc (MDV)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 24928% more annual revenue ($11.77B vs $47.01M). WELL leads profitability with a 12.0% profit margin vs 0.3%. WELL earns a higher WallStSmart Score of 57/100 (C).

MDV

Avoid

32

out of 100

Grade: F

Growth: 2.7Profit: 5.5Value: 5.0Quality: 5.5
Piotroski: 4/9Altman Z: 0.21

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 2.0Quality: 7.0
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for MDV.

WELLSignificantly Overvalued (-78.3%)

Margin of Safety

-78.3%

Fair Value

$116.05

Current Price

$200.84

$84.79 premium

UndervaluedFair: $116.05Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

MDV2 strengths · Avg: 10.0/10
Price/BookValuation
1.2x10/10

Reasonable price relative to book value

Operating MarginProfitability
40.9%10/10

Strong operational efficiency at 40.9%

WELL3 strengths · Avg: 9.7/10
Revenue GrowthGrowth
38.3%10/10

Revenue surging 38.3% year-over-year

EPS GrowthGrowth
157.9%10/10

Earnings expanding 157.9% YoY

Market CapQuality
$137.90B9/10

Large-cap with strong market position

Areas to Watch

MDV4 concerns · Avg: 3.0/10
Market CapQuality
$188.92M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.1%3/10

ROE of 0.1% — below average capital efficiency

Profit MarginProfitability
0.3%3/10

0.3% margin — thin

Debt/EquityHealth
1.763/10

Elevated debt levels

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.2%3/10

ROE of 3.2% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
94.4x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : MDV

The strongest argument for MDV centers on Price/Book, Operating Margin.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, EPS Growth, Market Cap. Revenue growth of 38.3% demonstrates continued momentum.

Bear Case : MDV

The primary concerns for MDV are Market Cap, Return on Equity, Profit Margin. Debt-to-equity of 1.76 is elevated, increasing financial risk. Thin 0.3% margins leave little buffer for downturns.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 94.4x leaves little room for execution misses.

Key Dynamics to Monitor

MDV profiles as a value stock while WELL is a growth play — different risk/reward profiles.

WELL carries more volatility with a beta of 0.82 — expect wider price swings.

WELL is growing revenue faster at 38.3% — sustainability is the question.

WELL generates stronger free cash flow (282M), providing more financial flexibility.

Bottom Line

WELL scores higher overall (57/100 vs 32/100) and 38.3% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Modiv Inc

REAL ESTATE · REIT - INDUSTRIAL · USA

Modiv Inc (MDV) is a prominent real estate investment trust (REIT) specializing in the acquisition and management of single-tenant net lease properties across the United States, primarily investing in essential and financially robust businesses. The company leverages a disciplined investment strategy focused on long-term lease agreements, which enhances income stability and offers opportunities for capital appreciation. Modiv Inc is dedicated to sustainability and innovation, positioning itself uniquely within the real estate market while striving to provide attractive risk-adjusted returns for its investors.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?